The majority (96%) of high grade serous carcinomas have TP53 mutations and show high levels of chromosomal copy number changes through the entire genome, whereas low grade serous carcinomas do not have TP53 mutations, show KRAS and BRAF mutations and in most cases are near diploid [3]. This evidence concerns the gene KRAS and serous adenocarcinoma.